Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares U.S. Health Care Providers ETF (NY:IHF)

45.11 -0.49 (-1.07%)
Streaming Delayed Price Updated: 10:39 AM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares U.S. Health Care Providers ETF

< Previous 1 2 Next >
Jim Cramer On Centene's 40% Crash: Fewer ACA Signups, Sicker Patients, Pulled Guidance And Major Earnings Hit Trigger Selloff: 'This Is Horrifying'
Shares of managed care provider Centene Corp. (NYSE: CNC) dropped over 40% on Wednesday, marking the worst single-day performance in the company's history. 
Via Benzinga
Trump's Tax Blitz Is An ETF Game-Changer—Are You Ready?
Major U.S. policy changes slash SNAP and Medicaid while introducing "Trump Accounts" for newborn investors. Explore how ETFs may be impacted across sectors. 
Via Benzinga
Topics ETFs Government
Why Elevance Health Shares Are Surging Premarket On Wednesday?
Elevance Health, Inc. (ELV) reaffirms 2025 EPS guidance and reports strong Q1 performance, despite Medicare audit concerns. ELV stock up 6.39% premarket. 
Via Benzinga
5 ETFs Withstanding The Biggest Market Drop Since 2020
Despite the broad indices’ losses, a few ETFs survived the market rout in April 3 trading session. 
Via Talk Markets
Topics ETFs
Biotech Rally Coming In Weeks Ahead?
Large cap biopharma and MedTech stocks are leading the healthcare sector higher. 
Via Talk Markets
Topics ETFs Stocks / Equities
Health Insurance ETFs in Focus as RFK Jr Takes Over HHS
Robert F. Kennedy Jr. has taken office as HHS secretary, which could impact the healthcare sector, including ETFs with exposure to insurers like UnitedHealth and Elevance Health. 
Via Benzinga
Topics ETFs
US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget
A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set for February 21. 
Via Benzinga
Cigna Stock Slips On More Price-Target Cuts After Weak Q4, But Retail Bets On A Rebound
Shares have climbed more than 5% since last week's earnings report, with many retail traders arguing the stock is oversold and offers an attractive entry point. 
Via Stocktwits
Quest Diagnostics Stock Hits Over 2-Month High On Q4 Beat, Dividend Hike: Retail Cheer Grows
Quest completed eight acquisitions in 2024, including LifeLabs, expanded its advanced diagnostics portfolio, and extended its market reach with new clinical, consumer, and health plan customers. 
Via Stocktwits
Cigna Group Stock Drops To Near 4-Week Low After Big Profit Miss, Retail Turns Bearish
The company revised its full-year 2025 adjusted EPS to $29.50, below the $31.48 estimate, and projected adjusted revenue of at least $252 billion. 
Via Stocktwits
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely. 
Via Benzinga
HCA Healthcare Stock Wobbles As Revenue Outlook Disappoints, But Retail’s Busy Cheering Q4 Profit Beat
The board approved a new $10 billion share repurchase program, which added to investor optimism. 
Via Stocktwits
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon
The firm’s medical-loss ratio (MLR) rose to 92.4% due to Medicaid-related costs but was better than expected. 
Via Stocktwits
World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements
Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate. 
Via Benzinga
Topics Government
ETFs In Focus Post UnitedHealth's Mixed Q4 Results
UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the... 
Via Talk Markets
Topics ETFs Stocks / Equities
Teladoc’s New Amazon Tie-Up Sparks Retail Sentiment Surge Even As Stock Swings Wildly
Following the ouster of CEO Jason Gorevic last year, the telehealth company has been trying to chart a recovery path. 
Via Stocktwits
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
Will Mark Cuban Join Rivals Elon Musk, Vivek Ramaswamy's DOGE? 'Shark Tank' Host Says 'Both Know How To Reach Me'
Mark Cuban has expressed willingness to collaborate with Elon Musk and Vivek Ramaswamy's Department of Government Efficiency (DOGE) by offering his Cost Plus Drug Company to help cut federal healthcare... 
Via Benzinga
Healthcare Stocks Are Coming On Strong In July Led By Biotech
The biotech rally gained momentum in July with rotation out of technology stocks. 
Via Talk Markets
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers. 
Via Benzinga
Topics Government
Biden To Sign Executive Order To Limit Asylum Seekers Crossing US-Mexico Border: Report
A Biden executive order comes after GOP Senators killed a bipartisan immigration bill earlier this year at the behest of Trump. 
Via Benzinga
Topics Immigration
GDP Growth Slows In Q1: 5 ETFs To Invest In
Investors should bet on defensive areas that will likely see growth even if the economy slows down. These include sectors like utilities, real estate, healthcare, and consumer staples, as well as... 
Via Talk Markets
Topics ETFs Economy
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment. 
Via InvestorPlace
Topics ETFs
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline. 
Via Benzinga
Topics Stocks
Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024
Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD. 
Via Talk Markets
5 Secret Santa ETFs That Might Surprise You This Christmas
Wall Street has been sizzling hot this holiday season. This is likely to continue, given that the Santa Claus rally is on the way. Against such a backdrop, there are some hidden gems which could... 
Via Talk Markets
Topics ETFs
Mark Cuban's Cost Plus Drugs Gets Medication Elon Musk Asked About 6 Months Ago: 'Still Ready To Save Tesla, SpaceX And X a F**kton of Money'
Cuban updated Musk, sharing a link to purchase Ivermectin on Cost Plus Drugs' website. 
Via Benzinga
Healthcare Portfolio Focus Stocks
The macro news has been a steady headwind with rising rates offering 5% risk-free treasury yields. 
Via Talk Markets
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment. 
Via Talk Markets
Healthcare Playbook Revisited - Growth Plus Value
Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on. 
Via Talk Markets
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.